|
000
| 01629cam 2200325za 4500 |
|---|
| 001 | 9.848935 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107153810 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 171215s2017 onc ob f000 0 eng d |
|---|
| 020 | |a978-0-660-24300-9 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-1/2018-1E-PDF |
|---|
| 245 | 00|aCanadian guidelines on sexually transmitted infections |h[electronic resource] : |bsupplementary statement for the management of Lymphogranuloma venereum (LGV) cases and contacts. |
|---|
| 246 | 30|aSupplementary statement for the management of Lymphogranuloma venereum (LGV) cases and contacts |
|---|
| 260 | |a[Ottawa : |bPublic Health Agency of Canada], |c2017. |
|---|
| 300 | |a3 p. |
|---|
| 500 | |aIssued also in French under title: Lignes directrices canadiennes sur les infections transmissibles sexuellement : déclaration supplémentaire pour la prise en charge des cas et des contacts de Lymphogranulomatose vénérienne (LGV). |
|---|
| 500 | |aCaption title. |
|---|
| 500 | |a"October 2017." |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 692 | 07|2gccst|aSexually transmitted diseases |
|---|
| 692 | 07|2gccst|aMedicine |
|---|
| 692 | 07|2gccst|aGuidelines |
|---|
| 693 | 4|aLymphogranuloma venereum |
|---|
| 710 | 2 |aPublic Health Agency of Canada. |
|---|
| 775 | 08|tLignes directrices canadiennes sur les infections transmissibles sexuellement |w(CaOODSP)9.848937 |
|---|
| 795 | |tSupplementary statement concerning the laboratory diagnosis of Lymphgranuloma Venereum (LGV) : |w(CaOODSP)9.700029 |
|---|
| 856 | 40|qPDF|s38 KB|uhttps://publications.gc.ca/collections/collection_2018/aspc-phac/HP40-1-2018-1-eng.pdf |
|---|